PHASE II PILOT TRIAL OF CONCURRENT BIOCHEMOTHERAPY WITH CISPLATIN, DACARBAZINE
PHASE II PILOT TRIAL OF CONCURRENT BIOCHEMOTHERAPY WITH CISPLATIN, DACARBAZINE
批准号:
6245550
负责人:
Michael Benjamin Atkins
金额:
$2.82万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-05-01 至 1997-11-30
中文摘要
这项研究将包括静脉注射DTIC,CDDP和
长春花碱同时皮下注射α-氨基丁酸
干扰素(Intron A)和连续四天的IL-2输注。这个
本研究的目的是确定DTIC的管理是否
顺铂、长春花碱联合IL-2持续输注
皮下注射干扰素能够产生
对肿瘤生长的影响。我们还希望确定这种药物的副作用
这种疗法以及实施这种治疗的潜在可行性
在社区医院环境中。
英文摘要
This study will involve the intravenous administration of DTIC, CDDP, and
Vinblastine concurrent with subcutaneous administration of alpha-
interferon (Intron A) and a four-day continous infusion of IL-2. The
purpose of this study is to determine whether the administration of DTIC
and CDDP and Vinblastine in combination with a continuous infusion of IL-2
and subcutaneous injections of interferon is capable of having an effect
on the growth of tumors. We also hope to determine the side effects of
this regimen and the potential feasibility of carrying out this treatment
in community hospital settings.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
(PQ #8) Biomarkers of efficacy and adverse events due to treatment with immune checkpoint inhibitors
-
批准号:10462570
-
项目类别:
-
资助金额:$52.27万
-
财政年份:2018
-
负责人:Michael Benjamin Atkins
-
依托单位:
(PQ #8) Biomarkers of efficacy and adverse events due to treatment with immune checkpoint inhibitors
-
批准号:10001451
-
项目类别:
-
资助金额:$53.33万
-
财政年份:2018
-
负责人:Michael Benjamin Atkins
-
依托单位:
Career Development Program
-
批准号:7742551
-
项目类别:
-
资助金额:$6.83万
-
财政年份:2009
-
负责人:Michael Benjamin Atkins
-
依托单位:
Developmental Research Program
-
批准号:7742550
-
项目类别:
-
资助金额:$13.65万
-
财政年份:2009
-
负责人:Michael Benjamin Atkins
-
依托单位:
DF/HCC Renal Cancer SPORE
-
批准号:7276728
-
项目类别:
-
资助金额:$233.06万
-
财政年份:2003
-
负责人:Michael Benjamin Atkins
-
依托单位:
DF/HCC Renal Cancer SPORE
-
批准号:6671085
-
项目类别:
-
资助金额:$250.0万
-
财政年份:2003
-
负责人:Michael Benjamin Atkins
-
依托单位:
DF/HCC Renal Cancer SPORE
-
批准号:6801547
-
项目类别:
-
资助金额:$244.77万
-
财政年份:2003
-
负责人:Michael Benjamin Atkins
-
依托单位:
DF/HCC Kidney Cancer SPORE
-
批准号:7910615
-
项目类别:
-
资助金额:$230.0万
-
财政年份:2003
-
负责人:Michael Benjamin Atkins
-
依托单位:
DF/HCC Renal Cancer SPORE
-
批准号:6941300
-
项目类别:
-
资助金额:$245.83万
-
财政年份:2003
-
负责人:Michael Benjamin Atkins
-
依托单位:
DF/HCC Kidney Cancer SPORE
-
批准号:7691537
-
项目类别:
-
资助金额:$230.0万
-
财政年份:2003
-
负责人:Michael Benjamin Atkins
-
依托单位:
DF/HCC Renal Cancer SPORE
-
批准号:7099645
-
项目类别:
-
资助金额:$240.03万
-
财政年份:2003
-
负责人:Michael Benjamin Atkins
-
依托单位:
Phase 1 Trial of twice weekly IV IL-12 plus low-dose subcutaneous IL-2
-
批准号:7043334
-
项目类别:
-
资助金额:$0.62万
-
财政年份:2003
-
负责人:Michael Benjamin Atkins
-
依托单位:
DF/HCC Renal Cancer SPORE
-
批准号:7644693
-
项目类别:
-
资助金额:$116.53万
-
财政年份:2003
-
负责人:Michael Benjamin Atkins
-
依托单位:
Biologic therapy of Melanoma and Renal Cell Cancer
-
批准号:6616195
-
项目类别:
-
资助金额:$11.37万
-
财政年份:2002
-
负责人:Michael Benjamin Atkins
-
依托单位:
Biologic therapy of Melanoma and Renal Cell Cancer
-
批准号:7073386
-
项目类别:
-
资助金额:$11.54万
-
财政年份:2002
-
负责人:Michael Benjamin Atkins
-
依托单位:
Biologic therapy of Melanoma and Renal Cell Cancer
-
批准号:6929773
-
项目类别:
-
资助金额:$11.49万
-
财政年份:2002
-
负责人:Michael Benjamin Atkins
-
依托单位:
Biologic therapy of Melanoma and Renal Cell Cancer
-
批准号:6522199
-
项目类别:
-
资助金额:$11.12万
-
财政年份:2002
-
负责人:Michael Benjamin Atkins
-
依托单位:
Biologic therapy of Melanoma and Renal Cell Cancer
-
批准号:6751543
-
项目类别:
-
资助金额:$11.45万
-
财政年份:2002
-
负责人:Michael Benjamin Atkins
-
依托单位:
Eastern Cooperative Oncology Group
-
批准号:6946936
-
项目类别:
-
资助金额:$12.87万
-
财政年份:1999
-
负责人:Michael Benjamin Atkins
-
依托单位:
Eastern Cooperative Oncology Group
-
批准号:7629144
-
项目类别:
-
资助金额:$13.09万
-
财政年份:1999
-
负责人:Michael Benjamin Atkins
-
依托单位:
海外基金